Skip to main content

MYL Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Viatris, Inc. News

Biogen Beats Third-Quarter Earnings, Cuts Guidance

Drugmaker Biogen's third-quarter results feel the effect of generic versions of its multiple sclerosis treatment.

Mylan Will Buy Aspen Pharmacare's Thrombosis Business

Mylan will acquire drugmaker Aspen Pharmacare's European thrombosis business for $757 million.

Gold, Moderna, Qualtrics, Coronavirus: 5 Things You Must Know

Gold surges to an all-time high amid worsening U.S.-China tensions; Wall Street prepares for a week heavy on tech earnings; Moderna secures an additional $472 million to develop a coronavirus vaccine.

Biogen Stock Off After Barclays Downgrade on Patent Ruling

Biogen is downgraded to equal weight by Barclays, which cited an adverse MS-drug patent ruling.

Biogen Loses Court Decision to Mylan Over Multiple Sclerosis Drug

A U.S. District Court judge rules that Mylan proved claims for Biogen’s patent for Tecfidera are invalid for 'lack of written description.'

Breaking News

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.

Birth Control Stocks May Benefit From the Reversal of Roe v. Wade

The historic Supreme Court decision may force women to make different choices.

Something Strange is Happening With Home Prices

As mortgage rates hit fresh highs, there's something unusual going on with the real estate market.

Roe Decision Forces Disney, Netflix to Take a Political Stand

Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.